PSHP 2026 Residency Conference has ended

PSHP 2026 Residency Conference

arrow_back View All Dates

9:30am EDT

Low- versus High- Dose Intravenous Methylprednisolone for High Eosinophilic Asthma and COPD Exacerbations in the Emergency Department a.Pavilion Hub WESTSherif Ahmed • Justin Miller, PharmD • Alexandra Chizmar

9:50am EDT

Intracranial Hemorrhage After Tenecteplase Administration for Acute Ischemic Stroke a.Pavilion Hub WESTSherif Ahmed • Justin Miller, PharmD • Sophia Ellis

10:10am EDT

Time to First Non-Benzodiazepine Antiseizure Medication in Status Epilepticus a.Pavilion Hub WESTSherif Ahmed • Justin Miller, PharmD • Kerim Cakir, PharmD, MS

10:40am EDT

Oral Stepdown Therapy for Gram-Negative Bacteremia in Obesity: High-Bioavailability Agents (Fluoroquinolones, Sulfamethoxazole-Trimethoprim) Versus Low-Bioavailability Agents (Beta-Lactams) a.Pavilion Hub WESTElisa Morgan • Adrienne Michelet • Danielle Miller • Abigail Zim, PharmD

11:00am EDT

Oral Third Generation Cephalosporins versus Standard of Care for the Treatment of Penicillin-non-susceptible, Ceftriaxone-susceptible Alpha-hemolytic Streptococcal Infections a.Pavilion Hub WESTElisa Morgan • Adrienne Michelet • Danielle Miller • Joseph Lalla

11:20am EDT

Comparison of Polymerase Chain Reaction (PCR) vs. Culture-Based Methicillin-Resistant Staphylococcus aureus (MRSA) Nasal Screenings on Time to Vancomycin De-escalation during Pneumonia Treatment a.Pavilion Hub WESTElisa Morgan • Adrienne Michelet • Danielle Miller • Anna Nahirnyak

11:40am EDT

Lunch Networking Infectious Diseases/Solid Organ Transplant a.Pavilion Hub WESTNatalie Kong, PharmD, BCPS

12:50pm EDT

Characterization of Delayed Infusion-Related Reactions with Polatuzumab vedotin (PV) a.Pavilion Hub WESTKristin Wheatley, PharmD, BCOP • Jeff Sivik, PharmD, BCOP • Hannah Igoe • Michael Roney

1:10pm EDT

Impact of a Clinic Based Solid Tumor Pharmacist, A Pilot Project a.Pavilion Hub WESTKristin Wheatley, PharmD, BCOP • Jeff Sivik, PharmD, BCOP • Hannah Igoe • Madison Trapeni

1:30pm EDT

Assessment Of The Efficacy Of IV Iron 1500 mg vs. 1000 mg On Hematologic Response a.Pavilion Hub WESTKristin Wheatley, PharmD, BCOP • Jeff Sivik, PharmD, BCOP • Hannah Igoe • Morgan Cherry

2:00pm EDT

Impact of bromocriptine on suspected neurogenic fever a.Pavilion Hub WESTMark Bennett • Jennifer Kunkel • Travis Reinaker • Maeghan Biché, PharmD

2:20pm EDT

Lorazepam Usage with a Gabapentin Taper vs. No Taper for Inpatient Management of Alcohol Withdrawal a.Pavilion Hub WESTMark Bennett • Jennifer Kunkel • Travis Reinaker • Lauryn Stark

2:40pm EDT

Fixed Dose versus Titratable Vasopressin in Septic Shock: A Retrospective Chart Review a.Pavilion Hub WESTMark Bennett • Jennifer Kunkel • Travis Reinaker • Emily Curtin

3:00pm EDT

Preceptor Pearl: Successful Failure in Precepting a.Pavilion Hub WESTJane McNoble • Melissa Tu, PharmD, BCPS

3:20pm EDT

Preceptor Pearl: Small Patients, Big Learning. Precepting in Pediatric Pharmacy a.Pavilion Hub WESTJane McNoble • Elizabeth Faville, PharmD, BCPPS

3:40pm EDT

Preceptor Pearl: Supporting Professional Identity Formation in Pharmacy Trainees a.Pavilion Hub WESTJane McNoble • Toni Mikhael